Slow degradation and aggregation in vitro of mutant GABAA receptor gamma2(Q351X) subunits associated with epilepsy.
Ontology highlight
ABSTRACT: The GABA(A) receptor ?2 subunit nonsense mutation Q351X has been associated with the genetic epilepsy syndrome generalized epilepsy with febrile seizures plus, which includes a spectrum of seizures types from febrile seizures to Dravet syndrome. Although most genetic epilepsy syndromes are mild and remit with age, Dravet syndrome has a more severe clinical course with refractory seizures associated with developmental delay and cognitive impairment. The basis for the broad spectrum of seizure phenotypes is uncertain. We demonstrated previously that the GABA(A) receptor ?2 subunit gene Q351X mutation suppressed biogenesis of wild-type partnering ?1 and ?2 subunits in addition to its loss of function. Here we show that ?2S(Q351X) subunits have an additional impairment of biogenesis. Mutant ?2(Q351X) subunits were degraded more slowly than wild-type ?2 subunits and formed SDS-resistant, high-molecular-mass complexes or aggregates in multiple cell types, including neurons. The half-life of ?2S(Q351X) subunits was ?4 h, whereas that of ?2S subunits was ?2 h. Mutant subunits formed complexes rapidly after synthesis onset. Using multiple truncated subunits, we demonstrated that aggregate formation was a general phenomenon for truncated ?2S subunits and that their Cys-loop cysteines were involved in aggregate formation. Protein aggregation is a hallmark of neurodegenerative diseases, but the effects of the mutant ?2S(Q351X) subunit aggregates on neuronal function and survival are unclear. Additional validation of the mutant subunit aggregation in vivo and determination of the involved signaling pathways will help reveal the pathological effects of these mutant subunit aggregates in the pathogenesis of genetic epilepsy syndromes.
SUBMITTER: Kang JQ
PROVIDER: S-EPMC2976503 | biostudies-literature | 2010 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA